Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
Open Access
- 3 March 2022
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-8
Abstract
Background: We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland. Methods: Finnish Cancer Registry data by histological diagnosis and tumor location (2007–2017) for cases with diffuse large B-cell lymphoma. Results: During 2007–2017, 392 new cases of PCNSL were reported (195 males, 197 females). The average age-adjusted incidence was 0.68/100,000 person-years. Incidence for males was 0.74/100,000 and for females 0.63/100,000, respectively. The incidence was highest, 2.93/100,000, among people aged 75–79 years. Concerning all cases in 2007–2017 the 2-year age-adjusted relative survival rate was 33% and the corresponding 5-year survival rate was 26%. Among patients under the age of 70, the age-adjusted 5-year relative survival rate increased from 36% in 2007–2012 to 43% for 2013–2017. Among patients aged 70+ the corresponding survival rates were poor, 7 and 9%. Conclusions: PCNSL incidence in Finland is among the highest reported in the world. The annual increase in incidence was 2.4%. The prognosis is still dismal, especially in elderly patients.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- Survival Outcomes of Primary Intraocular LymphomaAmerican Journal of Clinical Oncology, 2016
- Primary CNS LymphomaCurrent Hematologic Malignancy Reports, 2014
- Delivery of Chemotherapeutics Across the Blood–Brain Barrier2014
- Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphomaAnnals of Oncology, 2013
- Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphomaLeukemia, 2011
- Racial differences in primary central nervous system lymphoma incidence and survival ratesNeuro-Oncology, 2009
- Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003Cancer, 2007
- Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in FinlandInternational Journal of Epidemiology, 2002
- Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot studyJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Clinicopathological Features, Survival And Prognostic Factors Of Primary Central Nervous System Lymphomas: Trends in Incidence of Primary Central Nervous System Lymphomas and Primary Malignant Brain Tumors in A Well-Defined Geographical Area; Population-Based Data from the Danish Lymphoma Registry, Lyfo, And the Danish Cancer ReistryLeukemia & Lymphoma, 1995